Combined Treatment with Laser Ablation and Tyrosine-Kinase Inhibitor as A Novel Multimodality Approach to Locally Advanced Thyroid Cancer: A Case Report

Title:Combined Treatment with Laser Ablation and Tyrosine-Kinase Inhibitor as A Novel Multimodality Approach to Locally Advanced Thyroid Cancer: A Case Report

Volume: 22 Issue: 3

Author(s): Agnese Persichetti, Salvatore Monti, Carmela Coccaro, Federica Presciuttini, Maria Grazia Deiana, Giancarlo Bizzarri, Antonio Bianchini, Vincenzo Triggiani, Enrico Papini*Rinaldo Guglielmi

Affiliation:

• Department of Endocrinology & Metabolism, Regina Apostolorum Hospital, Rome, Italy

Keywords: Thyroid cancer, laser ablation, thermal ablation, locally advanced cancer, multimodality treatment, ultrasound- guided procedure.

Abstract:

Background: Direct locoregional treatments were recently proposed for the local control of cervical and distant metastasis of thyroid cancer, but data on their use as part of a multimodality approach for primary thyroid tumors are poor. In this feasibility study, laser ablation (LTA) was successfully used for the initial debulking of unresectable radioiodine-refractory thyroid cancer in sequential therapy with Tyrosine-Kinase Inhibitors (TKI).

Case Presentation: A 69-year-old woman underwent partial resection of papillary thyroid cancer with extensive tracheal infiltration. Post-treatment whole-body scan (¹³¹I, 8140 MBq) showed the absence of cervical thyroid uptake. The patient experienced a rapid increase in her cervical mass associated with dysphonia, dyspnea, and dysphagia. Due to a concomitant severe hypertensive state and cardiac failure, the patient was treated with LTA after a multidisciplinary consultation. After local anesthesia, two 300 nm optic fibers were inserted into the lesion through 21G spinal needles. Two illuminations with 4-watt output power and 3600 Joules energy delivery were performed with a diode-laser source. LTA resulted in rapid cancer debulking, and mass volume decreased from 23.9 to 7.5 mL resulting in significant improvement of pressure symptoms. Three months later, the patient was started on lenvatinib due to the initial regrowth of the tumor mass. The cervical tumor burden was controlled by TKI for 20 months when a rapid disease progression occurred, and the patient died.

Discussion: Locally advanced, unresectable, and radioiodine-refractory thyroid tumors can be managed with a novel multimodality approach. The initial debulking with LTA of the locally aggressive disease results in rapid control of the tumor burden threatening patients’ life and is effectively followed by long-term control with TKI treatment.

Conclusion: Based on this experience, sequential multimodality treatment with an initial locally directed laser ablation procedure followed by TKI therapy may be considered as a salvage option in patients with unresectable and rapidly progressive RR thyroid tumors.

Cite this article as:

Persichetti Agnese , Monti Salvatore , Coccaro Carmela , Presciuttini Federica , Deiana Grazia Maria , Bizzarri Giancarlo , Bianchini Antonio , Triggiani Vincenzo , Papini Enrico *, Guglielmi Rinaldo , Combined Treatment with Laser Ablation and Tyrosine-Kinase Inhibitor as A Novel Multimodality Approach to Locally Advanced Thyroid Cancer: A Case Report, Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22 (3) . https://dx.doi.org/10.2174/1871530321666210830093522